ACTIVE

UCB PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

4,2 Md €

+347.5% YoY

Revenue

4,6 Md €

+9.8% YoY

Equity

16,2 Md €

+31.0% YoY

Workforce

1 960,6 ETP

+12.3% YoY

What does UCB PHARMA do?

UCB PHARMA is a Public limited company incorporated in 1968. Its registered office is in Anderlecht. It employs on average 1 960,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0403.096.168

Incorporation

01/02/1968

Legal form

Public limited company

Registered office

Allée de la Recherche 60
1070 Anderlecht · BruxellesSee on map

Contributed capital

7 804 773 810,00 €

Latest accounts

31/12/2025

Average workforce

1 960,6 ETP

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Revenue	4,6 Md €	+9.8%	4,2 Md €	+32.6%	3,2 Md €	-3.6%	3,3 Md €	-4.0%	3,4 Md €	-11.4%	3,9 Md €	+19.3%	3,2 Md €	+20.6%	2,7 Md €	+15.3%	2,3 Md €	+4.7%	2,2 Md €	+19.9%	1,9 Md €	+44.6%	1,3 Md €	+11.8%	1,1 Md €	+6.6%	1,1 Md €	+0.0%	1,1 Md €	-6.7%	1,2 Md €	+87.7%	615,9 M €	-51.7%	1,3 Md €
EBITDA	451,1 M €	-59.5%	1,1 Md €	+23.7%	899,9 M €	-20.3%	1,1 Md €	+44.7%	780,8 M €	+3.8%	752,0 M €	-7.3%	811,3 M €	+33.3%	608,9 M €	-3.4%	630,6 M €	+51.2%	417,0 M €	+6.3%	392,2 M €	+46.9%	267,0 M €	-56.2%	609,0 M €	+29.9%	468,7 M €	-12.8%	537,6 M €	-19.3%	666,6 M €	+205%	218,6 M €	-72.6%	797,0 M €
Operating result	334,7 M €	-67.4%	1,0 Md €	+17.7%	872,8 M €	-11.5%	985,7 M €	+47.4%	668,9 M €	+5.1%	636,7 M €	-10.3%	709,8 M €	+45.1%	489,2 M €	-10.3%	545,4 M €	+59.6%	341,8 M €	+10.3%	309,8 M €	+60.5%	193,0 M €	+433%	-57,9 M €	+63.0%	-156,6 M €	-254%	-44,3 M €	-153%	83,1 M €	+127%	-312,5 M €	-256%	199,7 M €
Net result	4,2 Md €	+347%	947,4 M €	+1.0%	938,1 M €	-1.1%	948,1 M €	+54.8%	612,6 M €	+6.6%	574,8 M €	+29.4%	444,3 M €	+1.1%	439,6 M €	-22.4%	566,7 M €	+15.2%	491,7 M €	+1711%	-30,5 M €	-189%	34,3 M €	-47.8%	65,8 M €	+126%	-256,5 M €	-948%	-24,5 M €	-111%	217,2 M €	+212%	-193,3 M €	+2.2%	-197,8 M €
Balance sheet
Equity	16,2 Md €	+31.0%	12,4 Md €	+5.1%	11,8 Md €	+5.2%	11,2 Md €	+15.1%	9,7 Md €	+4.4%	9,3 Md €	+211%	3,0 Md €	+27.6%	2,4 Md €	+23.0%	1,9 Md €	+42.1%	1,3 Md €	+117%	621,2 M €	-4.7%	651,8 M €	+5.6%	617,4 M €	+11.9%	551,6 M €	-31.7%	808,1 M €	-3.0%	832,6 M €	+315%	200,5 M €	+475%	34,8 M €
Total assets	20,7 Md €	+26.4%	16,4 Md €	+8.0%	15,2 Md €	+4.3%	14,6 Md €	+24.4%	11,7 Md €	+0.4%	11,7 Md €	+106%	5,7 Md €	-1.3%	5,7 Md €	+22.2%	4,7 Md €	+11.4%	4,2 Md €	+8.8%	3,9 Md €	+0.3%	3,9 Md €	-15.9%	4,6 Md €	+11.6%	4,1 Md €	-11.5%	4,7 Md €	+9.4%	4,3 Md €	+11.3%	3,8 Md €	-4.5%	4,0 Md €
Cash	7,9 M €	-28.8%	11,1 M €	+43.9%	7,7 M €	-54.4%	16,8 M €	+2272%	710,3 k €	-46.5%	1,3 M €	-71.3%	4,6 M €	-86.0%	33,1 M €	+93.5%	17,1 M €	+133%	7,3 M €	-58.3%	17,6 M €	+152%	7,0 M €	-99.6%	1,8 Md €	+46009%	4,0 M €	+91.8%	2,1 M €	+78.4%	1,2 M €	-49.6%	2,3 M €	-47.1%	4,4 M €
Debts	4,4 Md €	+11.8%	3,9 Md €	+18.1%	3,3 Md €	+0.2%	3,3 Md €	+73.9%	1,9 Md €	-13.7%	2,2 Md €	-15.5%	2,6 Md €	-22.2%	3,3 Md €	+21.6%	2,7 Md €	-2.7%	2,8 Md €	-12.4%	3,2 Md €	+2.7%	3,1 Md €	-14.9%	3,7 Md €	+14.5%	3,2 Md €	-6.7%	3,4 Md €	+20.7%	2,9 Md €	-2.5%	2,9 Md €	-1.1%	3,0 Md €
Other
Workforce	1 960,6 ETP	+12.3%	1 746,4 ETP	+19.3%	1 464,4 ETP	+6.8%	1 371,1 ETP	+3.4%	1 326,1 ETP	+4.7%	1 266,2 ETP	+17.3%	1 079,1 ETP	+5.4%	1 024,0 ETP	+4.1%	983,8 ETP	+5.1%	935,9 ETP	+4.2%	897,9 ETP	-25.2%	1 200,3 ETP	-34.2%	1 825,0 ETP	+0.8%	1 809,9 ETP	+3.7%	1 745,2 ETP	-0.5%	1 754,6 ETP	-10.4%	1 959,3 ETP	-15.1%	2 308,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

more than 1.000 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 51 ended

Active mandates

Jean-Christophe TELLIER

Chairman of the board of directors · since 10 mai 2023 · until 09 mai 2029

Active

Caroline VANCOILLIE

Director · since 11 mai 2022 · until 10 mai 2028

Active

Kirsten LUND-JÜRGENSEN

Director · since 11 mai 2022 · until 10 mai 2028

Active

Ended mandates

Charl VAN ZYL

Director · since 10 mai 2023 · until 01 juillet 2023

Ended

Charl VAN ZYL

Director · since 13 mai 2020 · until 09 mai 2023

Ended

Jean-Christophe TELLIER

Chairman of the board of directors · since 13 mai 2020 · until 09 mai 2023

Ended

Kirsten LUND-JÜRGENSEN

Director · since 18 juillet 2019 · until 11 mai 2022

Ended

At this address

Other companies at this address

Company	CBE no.
Fondation Emmanuel Janssen● Active	0408.369.901
U C B● Active	0403.053.608
UCB Belgium● Active	0402.040.254
UCB BIOPHARMA● Active	0543.573.053
UCB Developed Brands● Active	1017.533.562
UCB Fipar● Active	0403.198.811
UCB Pillar 2● Active	1011.675.752
UCB Ventures● Active	0667.816.096
UCB Ventures Belgium● Active	0668.388.891
UNITE TVA UCB● Active	0820.436.985

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/05/2026	19/05/2025	06/08/2024	17/05/2023	23/05/2022	30/04/2021
General meeting	13/05/2026	14/05/2025	08/05/2024	10/05/2023	11/05/2022	27/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	13/05/2026	19/05/2026	French	PDF
Full model	31/12/2024	14/05/2025	19/05/2025	French	PDF
Full modelCorrection	31/12/2023	08/05/2024	06/08/2024	French	PDF
Full model	31/12/2023	08/05/2024	13/05/2024	French	PDF
Full model	31/12/2022	10/05/2023	17/05/2023	French	PDF
Full model	31/12/2021	11/05/2022	23/05/2022	French	PDF
Full model	31/12/2020	27/04/2021	30/04/2021	French	PDF
Full model	31/12/2019	13/05/2020	18/05/2020	French	PDF
Full model	31/12/2018	08/05/2019	10/05/2019	French	PDF
Full model	31/12/2017	09/05/2018	28/05/2018	French	PDF
Full model	31/12/2016	10/05/2017	22/05/2017	French	PDF
Full model	31/12/2015	11/05/2016	24/05/2016	French	PDF
Full model	31/12/2014	13/05/2015	29/05/2015	French	PDF
Full model	31/12/2013	14/05/2014	08/08/2014	French	PDF
Full model	31/12/2012	28/06/2013	02/08/2013	French	PDF
Full model	31/12/2011	14/05/2012	20/06/2012	French	PDF
Full model	31/12/2010	11/05/2011	12/05/2011	French	PDF
Full model	31/12/2009	12/05/2010	18/05/2010	French	PDF
Full model	31/12/2008	13/05/2009	29/06/2009	French	PDF
Full model	31/12/2007	13/05/2008	13/06/2008	French	PDF
Full model	31/12/2006	09/05/2007	31/05/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 51 ended

Active mandates

Jean-Christophe TELLIER

Chairman of the board of directors · since 10 mai 2023 · until 09 mai 2029

Active

Caroline VANCOILLIE

Director · since 11 mai 2022 · until 10 mai 2028

Active

Kirsten LUND-JÜRGENSEN

Director · since 11 mai 2022 · until 10 mai 2028

Active

Ended mandates

Charl VAN ZYL

Director · since 10 mai 2023 · until 01 juillet 2023

Ended

Charl VAN ZYL

Director · since 13 mai 2020 · until 09 mai 2023

Ended

Jean-Christophe TELLIER

Chairman of the board of directors · since 13 mai 2020 · until 09 mai 2023

Ended

Kirsten LUND-JÜRGENSEN

Director · since 18 juillet 2019 · until 11 mai 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates10/09/2026
Nomination d'un administrateur - Fin de mandat d'un administrateur
PDF
Mandates17/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates26/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates04/08/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates04/08/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares28/07/2022
CAPITAL, ACTIONS
PDF
Mandates23/06/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates09/07/2021
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20254,2 Md €↑
2024
Annual accounts 2024947,4 M €↑
26/07/2024
nominationMyriam Juckler — déléguée chargée de la gestion journalière
08/05/2024
nominationSébastien Schueremans — commissaire aux comptes (représentant permanent de Mazars Bedrijfsrevisoren - Réviseurs d'Entreprises BV/SRL)
2023
Annual accounts 2023938,1 M €↓
10/05/2023
reconductionJean-Christophe Tellier — administrateur
10/05/2023
reconductionCharl van Zyl — administrateur
2022
Annual accounts 2022948,1 M €↑
15/07/2022
augmentation_capital
15/07/2022
apport
11/05/2022
reconductionKirsten Lund-Jürgensen — administrateur
11/05/2022
reconductionCaroline Vancoillie — administrateur
2021
Annual accounts 2021612,6 M €↑
2020
Annual accounts 2020574,8 M €↑
16/10/2020
reconductionGeoffroy Folie — délégué à la gestion journalière
2019
Annual accounts 2019444,3 M €↑
2018
Annual accounts 2018439,6 M €↓
2017
Annual accounts 2017566,7 M €↑
2016
Annual accounts 2016491,7 M €↑
2015
Annual accounts 2015-30,5 M €↓
2014
Annual accounts 201434,3 M €↓
2013
Annual accounts 201365,8 M €↑
2012
Annual accounts 2012-256,5 M €↓
2011
Annual accounts 2011-24,5 M €↓
2010
Annual accounts 2010217,2 M €↑
2009
Annual accounts 2009-193,3 M €↑
2008
Annual accounts 2008-197,8 M €
01/02/1968
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

UCB PHARMA

Overview

What does UCB PHARMA do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline